SRPT Sarepta Therapeutics, Inc.
SRPT Sarepta Therapeutics, Inc.
Healthcare · Biotechnology
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 bear converging
POC $17.39 · VWAP $19.23 · -7.8% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
2 watchlists
SRPT Price Structure
Loading timeframes…
Peers
Every watchlist SRPT belongs to, members best 30-day change first — SRPT highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@ibb
@biotech-scan
Against street estimates
How SRPT's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about SRPT from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 7 days ago · Oct 16
- SRPT News Today | Why did Sarepta Therapeutics stock go up today? $SRPT
- SRPT 8-K Filings - Sarepta Therapeutics Inc SEC 8-K
- Sarepta Therapeutics Announces Second Quarter 2026 Financial Results and Recent Corporate Developments - BioSpace
- Sarepta Therapeutics Q2 Earnings Call Highlights
- Sarepta Therapeutics Announces Second Quarter 2026 Financial Results and Recent Corporate Developments
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
SRPT research tape
42 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.